118
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Serum sestrin 2 levels in patients with uterine leiomyomas

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon

References

  • Ala, M., 2022. Sestrin2 in cancer: a foe or a friend? Biomarker Research, 10 (1), 29.
  • Andersen, J., 1998. Factors in fibroid growth. Bailliere’s Clinical Obstetrics and Gynaecology, 12 (2), 225–243.
  • Batlle, E. and Clevers, H., 2017. Cancer stem cells revisited. Nature Medicine, 23 (10), 1124–1134.
  • Byun, J.-K., et al., 2017. A positive feedback loop between Sestrin2 and mTORC2 ıs required for the survival of glutamine-depleted lung cancer cells. Cell Reports, 20 (3), 586–599.
  • Chae, H.S., et al., 2020. Sestrin 2 expression has regulatory properties and prognostic value in lung cancer. Journal of Personalized Medicine, 10 (3), 109.
  • Chen, K.-B., et al., 2016. Sestrin 2 expression is a favorable prognostic factor in patients with non-small cell lung cancer. American Journal of Translational Research, 8 (4), 1903–1909.
  • Chiaffarino, F., et al., 2016. Cigarette smoking and risk of uterine myoma: systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 197, 63–71.
  • Chiaffarino, F., et al., 2017. Alcohol consumption and risk of uterine myoma: a systematic review and meta analysis. PLoS One, 12 (11), e0188355.
  • Farquhar, C.M. and Steiner, C.A., 2002. Hysterectomy rates in the United States 1990–1997. Obstetrics and Gynecology, 99 (2), 229–234.
  • Gonzalez-Mercado, V.J., Fridley, B.L. and Saligan, L.N., 2018. Sestrin family of genes and their role in cancer-related fatigue. Supportive Care in Cancer, 26 (7), 2071–2074.
  • Haidurov, A. and Budanov, A.V., 2020. Sestrin family – the stem controlling healthy ageing. Mechanisms of Ageing and Development, 192, 111379.
  • Laganà, A.S., et al., 2017. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Archives of Gynecology and Obstetrics, 296 (5), 855–867.
  • Lee, J.H., Budanov, A.V. and Karin, M., 2013. Sestrins orchestrate cellular metabolism to attenuate aging. Cell Metabolism, 18 (6), 792–801.
  • Liang, Y., et al., 2016. SESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancers. Autophagy, 12 (8), 1229–1239.
  • McWilliams, M.M. and Chennathukuzhi, V.M., 2017. Recent advances in uterine fibroid etiology. Seminars in Reproductive Medicine, 35 (2), 181–189.
  • Parazzini, F., et al., 2003. Uterine fibroids risk and history of selected medical conditions linked with female hormones. European Journal of Epidemiology, 19 (3), 249–253.
  • Rein, M.S., Barbieri, R.L. and Friedman, A.J., 1995. Progesterone: a critical role in the pathogenesis of uterine myomas. American Journal of Obstetrics and Gynecology, 172 (1 Pt 1), 14–18.
  • Ro, S.-H., et al., 2016. Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. eLife, 5, e12204.
  • Saeedi, V., et al., 2021. Sestrin2 and Beclin1 levels in polycystic ovary syndrome. Journal of Clinical Laboratory Analysis, 35 (9), e23957.
  • Shin, J., et al., 2020. mTOR-dependent role of Sestrin2 in regulating tumor progression of human endometrial cancer. Cancers, 12 (9), 2515.
  • Styer, A.K. and Rueda, B.R., 2016. The epidemiology and genetics of uterine leiomyoma. Best Practice & Research. Clinical Obstetrics & Gynaecology, 34, 3–12.
  • Vitagliano, A., et al., 2018. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Archives of Gynecology and Obstetrics, 297 (4), 823–835.
  • Wei, J.-L., et al., 2017. Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer. Oncotarget, 8 (30), 49318–49328.
  • Whitaker, L. and Critchley, H.O.D., 2016. Abnormal uterine bleeding. Best Practice & Research. Clinical Obstetrics & Gynaecology, 34, 54–65.
  • Wise, L.A. and Laughlin-Tommaso, S.K., 2016. Epidemiology of uterine fibroids: from Menarche to Menopause. Clinical Obstetrics and Gynecology, 59 (1), 2–24.
  • Wolman, I., 2014. Berek and Novak’s Gynecology 15th Edition. The Journal of Obstetrics and Gynecology of India, 64 (2), 150–151.
  • Xu, X., et al., 2021. Inhibition of sestrin 1 alleviates polycystic ovary syndrome by decreasing autophagy. Aging, 13 (8), 11774–11785.
  • Zhao, B., et al., 2014. Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells. The Journal of Biological Chemistry, 289 (52), 35806–35814.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.